Use access key #2 to skip to page content.
$5.75 -0.74 (-11.40%)
12/1/2008 1:52 PM

Celldex Therapeutics, Inc. (CLDX)

CAPS Rating:
*****

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

View All Commentary (CLDX)

Recs

0

Avatar Actionman2go (< 20) Submitted: 9/24/08 8:47 AM : Outperform Start Price: $11.99 CLDX Score: -25.01

Promising brain cancer drug manufacturer. Has gone up 744 percent since I started following it two years ago at a $1.42 stock price.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links